In vivo mesenchymal cell recruitment by a scaffold loaded with transforming growth factor beta1 and the potential for in situ chondrogenesis.
The objectives of this study were (1) to develop a biphasic implant made of a bioresorbable polymeric scaffold in combination with TGF-beta1-loaded fibrin glue for tissue-engineering applications, and (2) to determine whether the implant made of a polycaprolactone (PCL) scaffold and TGF-beta1-loaded fibrin glue could recruit mesenchymal cells and induce the process of cartilage formation when implanted in ectopic sites. Twenty-four 6-month-old New Zealand White rabbits were used. Scaffolds loaded with various doses of TGF-beta1 in fibrin glue were implanted subcutaneously, intramuscularly, and subperiosteally. The rabbits were killed and implants were removed at 2, 4, and 6 weeks postoperatively. The specimens were subjected to various staining techniques for histological analysis. Light microscopic examination of all specimens revealed that the entire pore space of the scaffolds was filled with various tissues in each group. The entire volume of the scaffolds in the groups loaded with TGF-beta1 and implanted intramuscularly and subcutaneously was populated with mesenchymal cells surrounded with an abundant extracellular matrix and blood vessels. The scaffold loaded with TGF-beta1 and implanted subperiosteally was found to be richly populated with chondrocytes at 2 and 4 weeks and immature bone formation was identified at 6 weeks. We conclude that scaffolds loaded with TGF-beta1 can successfully recruit mesenchymal cells and that chondrogenesis occurred when this construct was implanted subperiosteally.
Huang
Q
Q
Department of Orthopedic Surgery, National University Hospital, National University of Singapore, 10 Kent Ridge Crescent, Singapore 119260.
Goh
J C H
JC
Hutmacher
D W
DW
Lee
E H
EH
D000818:Animals; D001672:Biocompatible Materials; D002633:Chemotaxis / Q000187:drug effects; D019902:Chondrocytes / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D020219:Chondrogenesis / Q000187:drug effects* / Q000502:physiology; D003094:Collagen / Q000378:metabolism; D004343:Drug Implants; D015718:Fibrin Tissue Adhesive; D011817:Rabbits; D023822:Tissue Engineering; D016212:Transforming Growth Factor beta / Q000008:administration & dosage*; D053773:Transforming Growth Factor beta1
D001672:Biocompatible Materials; D004343:Drug Implants; D015718:Fibrin Tissue Adhesive; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1; D003094:Collagen